Subscribe

Sphere Corp. (347700.KQ)

KRW20,000.00 +110.00 (+0.55%)
KR KOE Healthcare Medical - Healthcare Information Services
Address Yeongchang Building
Seoul, KR
CEO Kwang Soo Choi
IPO 2021-03-23
ISIN KR7347700007

Explore sections of this company profile

Description

Sphere Corp. is a provider of advanced digital healthcare technology and holistic life care products and services. A core offering is LifeRecord, a proprietary personal health record platform designed to centralize and manage various health data points, including medical histories, genomic information, and user-generated health metrics. The company also offers a suite of digital healthcare services directly to consumers, which includes virtual treatment options, medication oversight, and general health and wellness management. Furthermore, Sphere Corp. facilitates patient communities, leveraging digital health enablement through solutions like digital therapeutics and artificial intelligence-powered software medical devices. Its product portfolio extends to manufacturing consumer medical devices for home use, professional medical equipment for healthcare settings, and a selection of other consumer goods. Established in Seoul, South Korea, in 2012, the company operated as LifeSemantics Corp. until its rebranding to Sphere Corp. in April 2025.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
KRW20,000.00 +110.00 (+0.55%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.71
Float Shares
20.03M
Free Float %
58.8%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+3.94% +0.36% -14.23% +55.15% +412.14% +121.06% +342.35% +799.79% +266.96% +141.14% +141.14%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
20,000.00
Quality scores
Altman Z-Score
29.23
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
2 / 5
Medium
ROA Score
3 / 5
Medium
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Healthcare Information Services: +14.2%
    +12.0% Q4'25: +1,081.9% (vs Q4'24)
  • EPS growth Medical - Healthcare Information Services: +43.1%
    -145.1%
  • FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    -12.5% Q4'25: +19.8% (vs Q4'24)
  • EBIT margin Medical - Healthcare Information Services: +8.8%
    +9.0% Q4'25: -65.5% (vs Q4'24)
  • ROIC Medical - Healthcare Information Services: +5.2%
    +11.2% Q4'25: -111.2% (vs Q4'24)
  • Share dilution Medical - Healthcare Information Services: -0.1%
    +121.0%
  • Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    1.38× Q4'25: -0.14× (vs Q4'24)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.95) × ERP
WACC = 99% × Ke + 1% × Kd (29.5%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 20,000.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-04-30 C 2/5 1/5 2/5 3/5 2/5 1/5 1/5
2026-04-29 C 2/5 1/5 2/5 4/5 2/5 1/5 1/5
2026-04-28 C 2/5 1/5 2/5 4/5 2/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
8.64B
OE per share TTM
201.64
Owner's Yield
0.48%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
5.2%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
191.19M
Shares Outstanding
34.05M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Byung Chul Choi VP, CFO & Inside director
Kwang Soo Choi Chairman of the Board of Directors & CEO
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings reports

Stock splits